#vrbpac — Public Fediverse posts

ICYMI (I did): #FDA has accepted the recommendation of its expert panel, #VRBPAC & recommended that Covid-19 vaccine manufacturers make a monovalent targeting the JN.1 lineage XFG variant.
How will #CDC handle the change? It would normally go to #ACIP but it's in limbo. https://www.fda.gov/vaccines-blood-biologics/industry-biologics/covid-19-vaccines-2026-2027-formula-use-united-states-beginning-fall-2026

ICYMI (I did): #FDA has accepted the recommendation of its expert panel, #VRBPAC & recommended that Covid-19 vaccine manufacturers make a monovalent targeting the JN.1 lineage XFG variant.
How will #CDC handle the change? It would normally go to #ACIP but it's in limbo. https://www.fda.gov/vaccines-blood-biologics/industry-biologics/covid-19-vaccines-2026-2027-formula-use-united-states-beginning-fall-2026

ICYMI (I did): #FDA has accepted the recommendation of its expert panel, #VRBPAC & recommended that Covid-19 vaccine manufacturers make a monovalent targeting the JN.1 lineage XFG variant.
How will #CDC handle the change? It would normally go to #ACIP but it's in limbo. https://www.fda.gov/vaccines-blood-biologics/industry-biologics/covid-19-vaccines-2026-2027-formula-use-united-states-beginning-fall-2026

ICYMI (I did): #FDA has accepted the recommendation of its expert panel, #VRBPAC & recommended that Covid-19 vaccine manufacturers make a monovalent targeting the JN.1 lineage XFG variant.
How will #CDC handle the change? It would normally go to #ACIP but it's in limbo. https://www.fda.gov/vaccines-blood-biologics/industry-biologics/covid-19-vaccines-2026-2027-formula-use-united-states-beginning-fall-2026

ICYMI (I did): #FDA has accepted the recommendation of its expert panel, #VRBPAC & recommended that Covid-19 vaccine manufacturers make a monovalent targeting the JN.1 lineage XFG variant.
How will #CDC handle the change? It would normally go to #ACIP but it's in limbo. https://www.fda.gov/vaccines-blood-biologics/industry-biologics/covid-19-vaccines-2026-2027-formula-use-united-states-beginning-fall-2026

FDA vaccine committee is meeting as we speak to select viral strains for fall flu shots. Everyone is a respected scientist. There are evidence-based presentations. We're an hour ahead of schedule. It's all so...normal. Quite the change of pace. #VRBPAC www.cidrap.umn.edu/influenza-va...

FDA vaccine advisers to meet t...

FDA vaccine committee is meeting as we speak to select viral strains for fall flu shots. Everyone is a respected scientist. There are evidence-based presentations. We're an hour ahead of schedule. It's all so...normal. Quite the change of pace. #VRBPAC www.cidrap.umn.edu/influenza-va...

FDA vaccine advisers to meet t...

FDA vaccine committee is meeting as we speak to select viral strains for fall flu shots. Everyone is a respected scientist. There are evidence-based presentations. We're an hour ahead of schedule. It's all so...normal. Quite the change of pace. #VRBPAC www.cidrap.umn.edu/influenza-va...

FDA vaccine advisers to meet t...

FDA vaccine committee is meeting as we speak to select viral strains for fall flu shots. Everyone is a respected scientist. There are evidence-based presentations. We're an hour ahead of schedule. It's all so...normal. Quite the change of pace. #VRBPAC www.cidrap.umn.edu/influenza-va...

FDA vaccine advisers to meet t...

FDA vaccine committee is meeting as we speak to select viral strains for fall flu shots. Everyone is a respected scientist. There are evidence-based presentations. We're an hour ahead of schedule. It's all so...normal. Quite the change of pace. #VRBPAC www.cidrap.umn.edu/influenza-va...

FDA vaccine advisers to meet t...

NEWS 2 September: Washington Post reports Dr Paul Offit, staunch vaccination advocate (and co-developer of a rotavirus vaccine) was ousted from his position on the FDA’s Vaccines and Related Biological Products Advisory Committee via email dated 28 August.

🎁 https://wapo.st/4lXDzbE
#VRBPAC

NEWS 2 September: Washington Post reports Dr Paul Offit, staunch vaccination advocate (and co-developer of a rotavirus vaccine) was ousted from his position on the FDA’s Vaccines and Related Biological Products Advisory Committee via email dated 28 August.

🎁 https://wapo.st/4lXDzbE
#VRBPAC

NEWS 2 September: Washington Post reports Dr Paul Offit, staunch vaccination advocate (and co-developer of a rotavirus vaccine) was ousted from his position on the FDA’s Vaccines and Related Biological Products Advisory Committee via email dated 28 August.

🎁 https://wapo.st/4lXDzbE
#VRBPAC

NEWS 2 September: Washington Post reports Dr Paul Offit, staunch vaccination advocate (and co-developer of a rotavirus vaccine) was ousted from his position on the FDA’s Vaccines and Related Biological Products Advisory Committee via email dated 28 August.

🎁 https://wapo.st/4lXDzbE
#VRBPAC

NEWS 2 September: Washington Post reports Dr Paul Offit, staunch vaccination advocate (and co-developer of a rotavirus vaccine) was ousted from his position on the FDA’s Vaccines and Related Biological Products Advisory Committee via email dated 28 August.

🎁 https://wapo.st/4lXDzbE
#VRBPAC

Update: The #FDA has already instructed #Covid vaccine manufacturers their fall shots should target LP.8.1, if they're able. Seems to leave room for Novavax not to update.
***
Today's #VRBPAC meeting on #Covid vaccines was a little unusual. The only vote was a no-brainer. On the more challenging question — should the vaccine strain be updated — they were of mixed minds, with some worrying an update might trigger new testing requirements. https://www.statnews.com/2025/05/22/fda-advisory-panel-split-on-whether-agency-should-require-updates-of-covid-19-vaccine/

Update: The #FDA has already instructed #Covid vaccine manufacturers their fall shots should target LP.8.1, if they're able. Seems to leave room for Novavax not to update.
***
Today's #VRBPAC meeting on #Covid vaccines was a little unusual. The only vote was a no-brainer. On the more challenging question — should the vaccine strain be updated — they were of mixed minds, with some worrying an update might trigger new testing requirements. https://www.statnews.com/2025/05/22/fda-advisory-panel-split-on-whether-agency-should-require-updates-of-covid-19-vaccine/

Update: The #FDA has already instructed #Covid vaccine manufacturers their fall shots should target LP.8.1, if they're able. Seems to leave room for Novavax not to update.
***
Today's #VRBPAC meeting on #Covid vaccines was a little unusual. The only vote was a no-brainer. On the more challenging question — should the vaccine strain be updated — they were of mixed minds, with some worrying an update might trigger new testing requirements. https://www.statnews.com/2025/05/22/fda-advisory-panel-split-on-whether-agency-should-require-updates-of-covid-19-vaccine/

Update: The #FDA has already instructed #Covid vaccine manufacturers their fall shots should target LP.8.1, if they're able. Seems to leave room for Novavax not to update.
***
Today's #VRBPAC meeting on #Covid vaccines was a little unusual. The only vote was a no-brainer. On the more challenging question — should the vaccine strain be updated — they were of mixed minds, with some worrying an update might trigger new testing requirements. https://www.statnews.com/2025/05/22/fda-advisory-panel-split-on-whether-agency-should-require-updates-of-covid-19-vaccine/

Update: The #FDA has already instructed #Covid vaccine manufacturers their fall shots should target LP.8.1, if they're able. Seems to leave room for Novavax not to update.
***
Today's #VRBPAC meeting on #Covid vaccines was a little unusual. The only vote was a no-brainer. On the more challenging question — should the vaccine strain be updated — they were of mixed minds, with some worrying an update might trigger new testing requirements. https://www.statnews.com/2025/05/22/fda-advisory-panel-split-on-whether-agency-should-require-updates-of-covid-19-vaccine/

Just submitted a comment regarding the #FDA's upcoming #VRBPAC committee meeting where they'll be deciding on this year's #COVID19 #vaccines. You can, too, before noon today!

https://www.regulations.gov/commenton/FDA-2025-N-1146-0001
#CovidIsNotOver

Just submitted a comment regarding the #FDA's upcoming #VRBPAC committee meeting where they'll be deciding on this year's #COVID19 #vaccines. You can, too, before noon today!

https://www.regulations.gov/commenton/FDA-2025-N-1146-0001
#CovidIsNotOver

Just submitted a comment regarding the #FDA's upcoming #VRBPAC committee meeting where they'll be deciding on this year's #COVID19 #vaccines. You can, too, before noon today!

https://www.regulations.gov/commenton/FDA-2025-N-1146-0001
#CovidIsNotOver

Just submitted a comment regarding the #FDA's upcoming #VRBPAC committee meeting where they'll be deciding on this year's #COVID19 #vaccines. You can, too, before noon today!

https://www.regulations.gov/commenton/FDA-2025-N-1146-0001
#CovidIsNotOver

Just submitted a comment regarding the #FDA's upcoming #VRBPAC committee meeting where they'll be deciding on this year's #COVID19 #vaccines. You can, too, before noon today!

https://www.regulations.gov/commenton/FDA-2025-N-1146-0001
#CovidIsNotOver

#HHS has canceled the March meeting of outside experts who were to advise #FDA on what next winter's #flu shots should target. The irony of this: Canceling #VRBPAC makes the US more reliant on the WHO-led strain selection process. https://www.statnews.com/2025/02/26/fda-cancels-vaccine-advisory-committee-meeting/

#HHS has canceled the March meeting of outside experts who were to advise #FDA on what next winter's #flu shots should target. The irony of this: Canceling #VRBPAC makes the US more reliant on the WHO-led strain selection process. https://www.statnews.com/2025/02/26/fda-cancels-vaccine-advisory-committee-meeting/

#HHS has canceled the March meeting of outside experts who were to advise #FDA on what next winter's #flu shots should target. The irony of this: Canceling #VRBPAC makes the US more reliant on the WHO-led strain selection process. https://www.statnews.com/2025/02/26/fda-cancels-vaccine-advisory-committee-meeting/

#HHS has canceled the March meeting of outside experts who were to advise #FDA on what next winter's #flu shots should target. The irony of this: Canceling #VRBPAC makes the US more reliant on the WHO-led strain selection process. https://www.statnews.com/2025/02/26/fda-cancels-vaccine-advisory-committee-meeting/

#HHS has canceled the March meeting of outside experts who were to advise #FDA on what next winter's #flu shots should target. The irony of this: Canceling #VRBPAC makes the US more reliant on the WHO-led strain selection process. https://www.statnews.com/2025/02/26/fda-cancels-vaccine-advisory-committee-meeting/

#VRBPAC votes unanimously to advise #FDA that this fall's #Covid shot should contain a JN.1-lineage virus. Committee was not asked to commit to a specific JN.1.
If there'd been a precise vote for KP.2 or KP.3, that might have precluded Novavax from the US market this fall. This is good news for them.

#VRBPAC votes unanimously to advise #FDA that this fall's #Covid shot should contain a JN.1-lineage virus. Committee was not asked to commit to a specific JN.1.
If there'd been a precise vote for KP.2 or KP.3, that might have precluded Novavax from the US market this fall. This is good news for them.

#VRBPAC votes unanimously to advise #FDA that this fall's #Covid shot should contain a JN.1-lineage virus. Committee was not asked to commit to a specific JN.1.
If there'd been a precise vote for KP.2 or KP.3, that might have precluded Novavax from the US market this fall. This is good news for them.

#VRBPAC votes unanimously to advise #FDA that this fall's #Covid shot should contain a JN.1-lineage virus. Committee was not asked to commit to a specific JN.1.
If there'd been a precise vote for KP.2 or KP.3, that might have precluded Novavax from the US market this fall. This is good news for them.

#VRBPAC votes unanimously to advise #FDA that this fall's #Covid shot should contain a JN.1-lineage virus. Committee was not asked to commit to a specific JN.1.
If there'd been a precise vote for KP.2 or KP.3, that might have precluded Novavax from the US market this fall. This is good news for them.

#FDA's vaccine experts, #VRBPAC, unanimously endorse taking the influenza B/Yamagata component out of #flu shots. And they seem to want the change to happen in time for the 2024-25 Northern Hemisphere shot rollout. Flu vax makers aren't convinced that's doable. https://www.statnews.com/2023/10/05/fda-expert-panel-endorses-idea-of-removing-a-component-from-flu-vaccine/

#FDA's vaccine experts, #VRBPAC, unanimously endorse taking the influenza B/Yamagata component out of #flu shots. And they seem to want the change to happen in time for the 2024-25 Northern Hemisphere shot rollout. Flu vax makers aren't convinced that's doable. https://www.statnews.com/2023/10/05/fda-expert-panel-endorses-idea-of-removing-a-component-from-flu-vaccine/

#FDA's vaccine experts, #VRBPAC, unanimously endorse taking the influenza B/Yamagata component out of #flu shots. And they seem to want the change to happen in time for the 2024-25 Northern Hemisphere shot rollout. Flu vax makers aren't convinced that's doable. https://www.statnews.com/2023/10/05/fda-expert-panel-endorses-idea-of-removing-a-component-from-flu-vaccine/

#FDA's vaccine experts, #VRBPAC, unanimously endorse taking the influenza B/Yamagata component out of #flu shots. And they seem to want the change to happen in time for the 2024-25 Northern Hemisphere shot rollout. Flu vax makers aren't convinced that's doable. https://www.statnews.com/2023/10/05/fda-expert-panel-endorses-idea-of-removing-a-component-from-flu-vaccine/

#FDA's vaccine experts, #VRBPAC, unanimously endorse taking the influenza B/Yamagata component out of #flu shots. And they seem to want the change to happen in time for the 2024-25 Northern Hemisphere shot rollout. Flu vax makers aren't convinced that's doable. https://www.statnews.com/2023/10/05/fda-expert-panel-endorses-idea-of-removing-a-component-from-flu-vaccine/

"For the 2023-2024 formulation of the COVID-19 vaccines for use in the U.S. beginning in the fall of 2023, the committee unanimously voted that the vaccine composition be updated to a monovalent COVID-19 vaccine with an XBB-lineage of the Omicron variant. Following discussion of the evidence, the committee expressed a preference for XBB.1.5."
https://www.fda.gov/vaccines-blood-biologics/updated-covid-19-vaccines-use-united-states-beginning-fall-2023
--
#FDA #VRBPAC #covid #XBB #vaccine

"For the 2023-2024 formulation of the COVID-19 vaccines for use in the U.S. beginning in the fall of 2023, the committee unanimously voted that the vaccine composition be updated to a monovalent COVID-19 vaccine with an XBB-lineage of the Omicron variant. Following discussion of the evidence, the committee expressed a preference for XBB.1.5."
https://www.fda.gov/vaccines-blood-biologics/updated-covid-19-vaccines-use-united-states-beginning-fall-2023
--
#FDA #VRBPAC #covid #XBB #vaccine

"For the 2023-2024 formulation of the COVID-19 vaccines for use in the U.S. beginning in the fall of 2023, the committee unanimously voted that the vaccine composition be updated to a monovalent COVID-19 vaccine with an XBB-lineage of the Omicron variant. Following discussion of the evidence, the committee expressed a preference for XBB.1.5."
https://www.fda.gov/vaccines-blood-biologics/updated-covid-19-vaccines-use-united-states-beginning-fall-2023
--
#FDA #VRBPAC #covid #XBB #vaccine

"For the 2023-2024 formulation of the COVID-19 vaccines for use in the U.S. beginning in the fall of 2023, the committee unanimously voted that the vaccine composition be updated to a monovalent COVID-19 vaccine with an XBB-lineage of the Omicron variant. Following discussion of the evidence, the committee expressed a preference for XBB.1.5."
https://www.fda.gov/vaccines-blood-biologics/updated-covid-19-vaccines-use-united-states-beginning-fall-2023
--
#FDA #VRBPAC #covid #XBB #vaccine

"For the 2023-2024 formulation of the COVID-19 vaccines for use in the U.S. beginning in the fall of 2023, the committee unanimously voted that the vaccine composition be updated to a monovalent COVID-19 vaccine with an XBB-lineage of the Omicron variant. Following discussion of the evidence, the committee expressed a preference for XBB.1.5."
https://www.fda.gov/vaccines-blood-biologics/updated-covid-19-vaccines-use-united-states-beginning-fall-2023
--
#FDA #VRBPAC #covid #XBB #vaccine

Novavax Fall 2023 Vaccine Booster Update

#Novavax presented at the June 15th #FDA #VRBPAC meeting to provide neutralization results from testing with various combinations of the original #vaccine, #BA.5, #XBB.1.5 and #XBB.1.16 #boosters. This thread will highlight the presentation. 🧵 1/

An unrolled one-page web view for this long thread that may be easier to read or share can be found here ( https://twitter.com/jeffgilchrist/status/1678356489449140226 )

Novavax Fall 2023 Vaccine Booster Update

#Novavax presented at the June 15th #FDA #VRBPAC meeting to provide neutralization results from testing with various combinations of the original #vaccine, #BA.5, #XBB.1.5 and #XBB.1.16 #boosters. This thread will highlight the presentation. 🧵 1/

An unrolled one-page web view for this long thread that may be easier to read or share can be found here ( https://twitter.com/jeffgilchrist/status/1678356489449140226 )

Novavax Fall 2023 Vaccine Booster Update

#Novavax presented at the June 15th #FDA #VRBPAC meeting to provide neutralization results from testing with various combinations of the original #vaccine, #BA.5, #XBB.1.5 and #XBB.1.16 #boosters. This thread will highlight the presentation. 🧵 1/

An unrolled one-page web view for this long thread that may be easier to read or share can be found here ( https://twitter.com/jeffgilchrist/status/1678356489449140226 )

Novavax Fall 2023 Vaccine Booster Update

#Novavax presented at the June 15th #FDA #VRBPAC meeting to provide neutralization results from testing with various combinations of the original #vaccine, #BA.5, #XBB.1.5 and #XBB.1.16 #boosters. This thread will highlight the presentation. 🧵 1/

An unrolled one-page web view for this long thread that may be easier to read or share can be found here ( https://twitter.com/jeffgilchrist/status/1678356489449140226 )

Novavax Fall 2023 Vaccine Booster Update

#Novavax presented at the June 15th #FDA #VRBPAC meeting to provide neutralization results from testing with various combinations of the original #vaccine, #BA.5, #XBB.1.5 and #XBB.1.16 #boosters. This thread will highlight the presentation. 🧵 1/

An unrolled one-page web view for this long thread that may be easier to read or share can be found here ( https://twitter.com/jeffgilchrist/status/1678356489449140226 )

There was lots of concern expressed at today's #VRBPAC meeting about preterm births & concomitant administration of vaccines during pregnancy. But at the end of the day, there was clear support for Pfizer's maternal #RSV vaccine to protect infants. https://www.statnews.com/2023/05/18/fda-advisory-panel-backs-pfizers-rsv-vaccine-but-expresses-some-safety-concerns/

There was lots of concern expressed at today's #VRBPAC meeting about preterm births & concomitant administration of vaccines during pregnancy. But at the end of the day, there was clear support for Pfizer's maternal #RSV vaccine to protect infants. https://www.statnews.com/2023/05/18/fda-advisory-panel-backs-pfizers-rsv-vaccine-but-expresses-some-safety-concerns/

There was lots of concern expressed at today's #VRBPAC meeting about preterm births & concomitant administration of vaccines during pregnancy. But at the end of the day, there was clear support for Pfizer's maternal #RSV vaccine to protect infants. https://www.statnews.com/2023/05/18/fda-advisory-panel-backs-pfizers-rsv-vaccine-but-expresses-some-safety-concerns/

There was lots of concern expressed at today's #VRBPAC meeting about preterm births & concomitant administration of vaccines during pregnancy. But at the end of the day, there was clear support for Pfizer's maternal #RSV vaccine to protect infants. https://www.statnews.com/2023/05/18/fda-advisory-panel-backs-pfizers-rsv-vaccine-but-expresses-some-safety-concerns/

There was lots of concern expressed at today's #VRBPAC meeting about preterm births & concomitant administration of vaccines during pregnancy. But at the end of the day, there was clear support for Pfizer's maternal #RSV vaccine to protect infants. https://www.statnews.com/2023/05/18/fda-advisory-panel-backs-pfizers-rsv-vaccine-but-expresses-some-safety-concerns/